---
title: "Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296658429.md"
description: "Gilead Sciences director Jeffrey Bluestone disposed of 5,000 common shares worth approximately $727,333.60 on August 20, 2026. He exercised stock options to acquire the shares at prices between USD 61.35 and 67.45, then sold them the same day for about USD 143.75 to 146.36 per share. Following these transactions, his direct holdings totaled 10,066 common shares."
datetime: "2026-08-21T23:22:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296658429.md)
  - [en](https://longbridge.com/en/news/296658429.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296658429.md)
generator: "portal-rs"
---

# Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60

-   Gilead director Jeffrey Bluestone exercised stock options on Aug. 20, 2026, acquiring 5,000 shares at USD 61.35 to USD 67.45. \* He sold 5,000 shares the same day at prices of about USD 143.75 to USD 146.36. \* Directly held common shares totaled 10,066 after the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gilead Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001771814-26-000005), on August 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [GILD.US](https://longbridge.com/en/quote/GILD.US.md)
- [GIS.DE](https://longbridge.com/en/quote/GIS.DE.md)

## Related News & Research

- [Advisors Capital Management LLC Takes Position in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/296674916.md)
- [GSA Capital Partners LLP Takes Position in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/296193567.md)
- [Grandfield & Dodd LLC Makes New Investment in Gilead Sciences, Inc. $GILD](https://longbridge.com/en/news/296196164.md)
- [European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across PD-L1 Status | GILD Stock News](https://longbridge.com/en/news/296773236.md)
- [02:10 ETKeymed Biosciences gibt Ergebnisse für das erste Halbjahr 2026 sowie aktuelle Geschäftsentwicklungen bekannt](https://longbridge.com/en/news/296866579.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**